Concepedia

Richard L. Monaghan

RL

30

Publications

4.3K

Citations

24

H-Index

1973

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

MSD K.K. (Japan)

Richard L. Monaghan is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, natural sciences, and biochemistry.

Top concepts

Publications per year

1973–1997

30

Publications

30

Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.

Alfred W. Alberts, J Chen, G. W. Kuron et al. · Proceedings of the National Academy of Sciences · 1980 · 1.6K citations · Full text

, , +19

Avermectins, New Family of Potent Anthelmintic Agents: Producing Organism and Fermentation

Richard W. Burg, Brinton M. Miller, Edward Baker et al. · Antimicrobial Agents and Chemotherapy · 1979 · 929 citations · Full text

A potent nonpeptide cholecystokinin antagonist selective for peripheral tissues isolated from Aspergillus alliaceus

Ray Chang, Virginia Lotti, Richard L. Monaghan et al. · Science · 1985 · 320 citations

, , +18

Avermectins, New Family of Potent Anthelmintic Agents: Isolation and Chromatographic Properties

Thomas W. Miller, Louis Chaiet, Douglas J. Cole et al. · Antimicrobial Agents and Chemotherapy · 1979 · 178 citations · Full text

Monoclonal antibodies against human erythrocyte band 3 protein. Localization of proteolytic cleavage sites and stilbenedisulfonate-binding lysine residues.

Michael L. Jennings, Matthew P. Anderson, Richard L. Monaghan · Journal of Biological Chemistry · 1986 · 123 citations · Full text

Rows per page

1–5 of 30